Expert Insights into Next-Generation Bioprocessing, Cell Line Development, and Advanced Manufacturing
Explore interviews, articles, session spotlights, and thought leadership from BioProcess International US West to keep you updated with pressing bioprocess development, continuous and upstream processing trends, as well as innovations in biologics and cell & gene therapies.
Bridging Innovation Across Disciplines in Bioprocessing
Gain new cross-functional perspectives that bring engineering, manufacturing, and data science together to advance next-generation biologics.
Expanding Horizons: Addressing Drug Product Development and Supply Chain Challenges at BioProcess International US West (BPI West) 2026
Explore how BPI West 2026 is addressing the biggest challenges in drug product development and supply chain resilience, and discover key insights shaping the future of bioprocessing.
Don't Miss These Sessions at BPI West:
Machine-Learning‐Enhanced Digital Twins for Quality Prediction
Discover how AI-powered digital twins are transforming process control and quality forecasting in the Manufacturing Strategy, AI and Bioprocessing 4.0 Track. A must-attend for scientists embracing data-led biomanufacturing.
High-Density CHO Cell Cultures as an Alternative to Perfusion for Productivity Enhancement
Join the discussion on how high-density CHO cultures are replacing or complementing perfusion systems - essential for upstream scientists and process-engineers seeking productivity gains, all part of the Cell Culture and Upstream Processing Track.
Scaling Genome-Edited Allogeneic CAR-T Manufacturing to Increase Access to Cell Therapies
Explore how allogeneic CAR-T manufacturing is being scaled up for broader access in the Cell and Gene Therapy Production and Commercialization Track – vital content for scientists, technology-leaders and executives steering advanced therapies.
Hot topics at BioProcess International US West 2026
How can we use AI or digital twins to accelerate bioprocess scale-up and reduce risk?
Digital twins and AI/ML models are transforming scale-up by predicting process outcomes and identifying risks before they impact production. This enables faster, safer tech transfers and optimized manufacturing.
What are the latest strategies for high-titer upstream processes and their impact on downstream bottlenecks?
Advances in high-titer upstream processes can create bottlenecks downstream, but strategies such as optimized perfusion and purification integration help maintain yield and efficiency.
What manufacturing challenges are currently faced in cell & gene therapy (CGT) production?
CGT production faces scale, cost, and regulatory hurdles. Sessions cover AAV manufacturing, quality control, and strategies to enable commercial-scale production.
How is cell line development evolving to improve productivity and reduce timelines?
Automation, robotics, and predictive modelling are accelerating clone selection and enhancing productivity while maintaining product quality.
How can data-driven strategies improve biomanufacturing control?
What are current approaches to downstream processing of high-titer biologics?
Optimized purification train design, resin management, and process intensification help maintain yield and quality in high-titer manufacturing environments.
How is Bioprocessing 4.0 enhancing supply chain and manufacturing resilience?
Integration of robotics, MES, and cloud-based data pipelines enables smarter, more resilient biomanufacturing, reducing downtime and improving efficiency.
New to the Bioprocessing / Biomanufacturing Sector?
Explore key definitions and foundational terms in bioprocessing, biomanufacturing, and biologics development. This glossary provides concise explanations to support readers who want quick clarity on core concepts referenced across the BPI West program, insights, and technical content.